Alison J. Yarnall1,2,3,4,5, David P. Breen1,2,3,4,5, Gordon W. Duncan1,2,3,4,5, Tien K. Khoo1,2,3,4,5, Shirley Coleman1,2,3,4,5, Michael Firbank1,2,3,4,5, Cristina Nombela1,2,3,4,5, Sophie Winder‐Rhodes1,2,3,4,5, Jonathan Evans1,2,3,4,5, James B. Rowe1,2,3,4,5, Brit Mollenhauer1,2,3,4,5, Niels Kruse1,2,3,4,5, Gavin Hudson1,2,3,4,5, Patrick F. Chinnery1,2,3,4,5, John T. O’Brien1,2,3,4,5, Trevor W. Robbins1,2,3,4,5, Keith Wesnes1,2,3,4,5, David J. Brooks1,2,3,4,5, Roger A. Barker1,2,3,4,5, David J. Burn1,2,3,4,5
1Centre for Human Psychopharmacology (K.W.), Swinburne University, Melbourne, Australia
2Department of Medicine (D.J.W.), Imperial College London, UK.
3From the Institute for Ageing and Health (A.J.Y., G.W.D., M.J.F., D.J.B.), Industrial Statistics Research Unit (S.Y.C.), and Institute of Genetic Medicine (G.H., P.F.C.), Newcastle University
4From the Institute for Ageing and Health (A.J.Y., G.W.D., M.J.F., D.J.B.), Industrial Statistics Research Unit (S.Y.C.), and Institute of Genetic Medicine (G.H., P.F.C.), Newcastle University; John van Geest Centre for Brain Repair (D.P.B., J.R.E., R.A.B.), Department of Clinical Neurosciences (C.N., S.W.-R., J.B.R.), Behavioural and Clinical Neuroscience Institute (C.N., S.W.-R., J.B.R., T.W.R.), MRC Cognition and Brain Sciences Unit (C.N., S.W.-R., J.B.R.), Departments of Psychiatry (J.T.O.) and...
5School of Medicine (T.K.K.), Griffith University, Australia
